BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 177797)

  • 1. Actions of papaverine on intestinal smooth muscle and its inhibition of cyclic AMP and cyclic GMP phosphodiesterases.
    Miyamoto M; Takayanagi I; Ohkubo H; Takagi K
    Jpn J Pharmacol; 1976 Feb; (1):114-7. PubMed ID: 177797
    [No Abstract]   [Full Text] [Related]  

  • 2. On the mechanism of relaxation of tracheal muscle by theophylline and other cyclic nucleotide phosphodiesterase inhibitors.
    Fredholm BB; Brodin K; Strandberg K
    Acta Pharmacol Toxicol (Copenh); 1979 Nov; 45(5):336-44. PubMed ID: 231892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agents.
    Murray KJ; England PJ
    Biochem Soc Trans; 1992 May; 20(2):460-4. PubMed ID: 1327922
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of isoenzyme-selective inhibitors of cyclic nucleotide phosphodiesterase on microvascular leak in guinea pig airways in vivo.
    Raeburn D; Karlsson JA
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1147-52. PubMed ID: 8263775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of NZ-105, a 1,4-dihydropyridine derivative, on cyclic nucleotide phosphodiesterase activity.
    Yamashita T; Masuda Y; Sakai T; Tanaka S; Kasuya Y
    J Pharm Pharmacol; 1993 Jun; 45(6):530-4. PubMed ID: 7689649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism by which psychotropic drugs inhibit adenosine cyclic 3',5'-monophosphate phosphodiesterase of brain.
    Levin RM; Weiss B
    Mol Pharmacol; 1976 Jul; 12(4):581-9. PubMed ID: 183095
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. I. A lack of correlation between inhibition of cyclic nucleotide phosphodiesterases and antigen-induced release of histamine from rat mast cells.
    Khandwala A; Van Inwegen R; Coutts S; Dally-Meade V; Jariwala N; Huang F; Musser J; Brown R; Loev B; Weinryb I
    Int Arch Allergy Appl Immunol; 1984; 73(1):56-64. PubMed ID: 6198287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties and drug responsiveness of cyclic nucleotide phosphodiesterases of rat lung.
    Fertel R; Weiss B
    Mol Pharmacol; 1976 Jul; 12(4):678-87. PubMed ID: 183099
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiphosphodiesterase activity and nonspecific smooth muscle relaxation tested on intestinal smooth muscles.
    Inatomi N; Takayanagi I; Takagi K
    Jpn J Pharmacol; 1975 Feb; 25(1):63-9. PubMed ID: 168424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc-mediated inhibition of cyclic nucleotide phosphodiesterase activity and expression suppresses TNF-alpha and IL-1 beta production in monocytes by elevation of guanosine 3',5'-cyclic monophosphate.
    von Bülow V; Rink L; Haase H
    J Immunol; 2005 Oct; 175(7):4697-705. PubMed ID: 16177117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta.
    Lugnier C; Schoeffter P; Le Bec A; Strouthou E; Stoclet JC
    Biochem Pharmacol; 1986 May; 35(10):1743-51. PubMed ID: 2423089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of papaverine derivatives on phosphodiesterase activity, cyclic 3',5'-AMP levels and relaxing effect on rabbit ileum.
    Berndt SF; Schulz HU; Stock K
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Sep; 294(3):271-5. PubMed ID: 187961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE; Lugnier C
    Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of cAMP and positive inotropic effect evoked by isoproterenol under the graded inhibition of phosphodiesterase by papaverine in the isolated rabbit papillary muscle.
    Endoh M; Brodde OE; Schümann HJ
    J Mol Cell Cardiol; 1975 Sep; 7(9):703-11. PubMed ID: 171423
    [No Abstract]   [Full Text] [Related]  

  • 15. Does sildenafil indirectly inhibit phosphodiesterase 3 in vascular smooth muscle?
    Maurice DH
    Hypertension; 2003 Mar; 41(3):e2. PubMed ID: 12623968
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries.
    Birk S; Edvinsson L; Olesen J; Kruuse C
    Eur J Pharmacol; 2004 Apr; 489(1-2):93-100. PubMed ID: 15063160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
    Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
    Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the inhibition of phosphodiesterase-catalyzed cyclic AMP and cyclic GMP breakdown and relaxation of canine tracheal smooth muscle.
    Polson JB; Krzanowski JJ; Fitzpatrick DF; Szentivanyi A
    Biochem Pharmacol; 1978 Jan; 27(2):254-6. PubMed ID: 203292
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective inhibition of cyclic AMP and cyclic GMP phosphodiesterases of cardiac nuclear fraction.
    Ahluwalia GS; Rhoads AR
    Biochem Pharmacol; 1982 Mar; 31(5):665-9. PubMed ID: 6177320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actions of dibutyryl cyclic adenosine monophosphate, papaverine and isoprenaline on the intestinal smooth muscle.
    Takagi K; Takayanagi I; Tomiyama A
    Jpn J Pharmacol; 1971 Aug; 21(4):477-83. PubMed ID: 4330225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.